Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder: An Open-Label Trial
The DOI matches its Crossref record.
Abstract
BACKGROUND: Dissociative phenomena, including flashbacks, are common in patients with borderline personality disorder and posttraumatic stress disorder (PTSD). Although dissociative symptoms can be severe and may interfere with psychotherapy, there is no established pharmacotherapy for these symptoms. Evidence suggests that alterations of the endogenous opiate system contribute to dissociative symptoms in patients with borderline personality disorder and PTSD. METHOD: We treated 2 groups of female borderline personality disorder patients (N = 13, with an overlap of 5 patients between the 2 groups; all met the diagnostic criteria of DSM-IV and the revised Diagnostic Interview for Borderline Patients) who experienced prominent dissociative phenomena including flashbacks with the nonselective opiate receptor antagonist naltrexone, 25 to 100 mg q.i.d., for at least 2 weeks. A self-rated questionnaire measuring dissociation, analgesia, tonic immobility, and tension (DAISS) was applied to 9 patients, who completed it for 7 consecutive days before and during treatment with naltrexone. In addition, 9 patients (with an overlap of 5 patients from the other group) completed a flashback protocol. RESULTS: DAISS scores reflected a highly significant reduction of the duration and the intensity of dissociative phenomena and tonic immobility as well as a marked reduction in analgesia during treatment with naltrexone. Six of 9 patients reported a decrease in the mean number of flashbacks per day. CONCLUSION: These observations support the hypothesis that an increased activity of the opioid system contributes to dissociative symptoms, including flashbacks, in borderline personality disorder and suggest that these symptoms may respond to treatment with opiate antagonists. In view of these results, a placebo-controlled, double-blind study to assess the potential benefit of naltrexone in a more rigorous way appears justified.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Longitudinal and case series studies of naltrexone and nalmefene in depersonalization disorder, borderline personality disorder, and PTSD also support opioid antagonist administration for reduced dissociative symptoms [116–119].”
From Treatment of dissociative identity disorder: leveraging neurobiology to optimize success (2024) · cites this paper as [117]
In the citing paper
“Finally, a handful of studies report successful reductions in dissociative symptoms, including depersonalization, following treatment with opioid-receptor antagonists (e.g., naloxone and naltrexone) among individuals with depersonalization disorder (Nuller et al., 2001;Simeon and Knutelska, 2005), and BPD (Bohus et al., 1999;Schmahl et al., 2012; but see Philipsen et al., 2004).”
From A review of the relation between dissociation, memory, executive functioning and social cognition in military members and civilians with neuropsychiatric conditions (2016) · cites this paper as Bohus et al., 1999
Citations
Cites
Still being checked.
Cited by
Items 101–153 of 153
Bohus, M., Stieglitz, R.-D. B., Fiedler, P. A., Hecht, H., Herpertz, S. C., Müller‐Isberner, R., & Berger, T. (2019) · Elsevier eBooks · doi:10.1016/b978-3-437-22485-0.00021-x · Cited by 3
Self-citationThe Treatment of Adult ADHD: Complexity at Hand
Pallanti, S., & Salerno, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-39051-8_19 · Cited by 4
Carvalho, A. F., Stracke, C. B., & Souza, F. G. D. M. E. (2004) · Revista de Psiquiatria do Rio Grande do Sul · doi:10.1590/s0101-81082004000200007 · Cited by 5
Goodman, M. S., Vail, L., West, S., New, A. S., & Siever, L. J. (2007) · International Journal of Systemic Therapy · doi:10.1300/j085v17n03_04 · Cited by 3
Functional Neurological Disorder and Dissociative Disorders in Women
Raynor, G., & Baslet, G. C. (2019) · Springer eBooks · doi:10.1007/978-3-030-04245-5_3 · Cited by 4
Estrategias en el tratamiento de desintoxicación alcohólica
Stauber, J. C. V. (2003) · Adicciones · doi:10.20882/adicciones.424 · Cited by 6
Anpassungsstörung, akute und posttraumatische Belastungsstörung
Kapfhammer, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_59 · Cited by 5
Pharmacologic treatment of personality disorder.
Rivas-Vazquez, R. A., & Blais, M. A. (2002) · Professional Psychology Research and Practice · doi:10.1037//0735-7028.33.1.104 · Cited by 3
Personality and Personality Disorders
Blais, M. A., Rivas-Vazquez, R. A., Ruchensky, J. R., & Stein, M. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11844-9.00037-0 · Cited by 2
Evidence-Based Pharmacotherapy for Personality Disorders
Ripoll, L. H., Triebwasser, J., & Siever, L. J. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.2.225 · Cited by 2
Bohus, M., Stieglitz, R., Fiedler, P. A., Hecht, H., Herpertz, S. C., Müller‐Isberner, R., & Berger, T. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22484-3.00021-9 · Cited by 2
Self-citationKapfhammer, H. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_73 · Cited by 2
The Inpatient with Borderline Personality Disorder
Hong, V., & Casher, M. I. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108656672.006 · Cited by 3
Schmeck, K., & Romanos, M. (2023) · Springer eBooks · doi:10.1007/978-3-662-65267-1_20 · Cited by 2
Anpassungsstörung, akute und posttraumatische Belastungsstörung
Kapfhammer, H. P. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_60 · Cited by 4
Pharmakotherapie der Akuten und Posttraumatischen Belastungsstörung
Kapfhammer, H. (2005) · Psychiatrie und Psychotherapie · doi:10.1007/s11326-005-0005-7 · Cited by 2
Kapfhammer, H. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_61 · Cited by 3
Kapfhammer, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_60 · Cited by 2
Borderline Personality Disorder
Emanuele, J. M., & Muehlenkamp, J. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-33228-4_83 · Cited by 2
Dziegielewski, S. F., & Jacinto, G. A. (2014) · Wiley eBooks · doi:10.1002/9781394260577.ch13 · Cited by 2
Persönlichkeits- und Impulskontrollstörungen — Neurobiologie
Schmahl, C. G., & Bohus, M. (2006) · Springer eBooks · doi:10.1007/3-540-30887-3_15 · Cited by 2
Self-citationTowards a pharmacology of depersonalization
Sierra, M. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511730023.009 · Cited by 1
Schmahl, C. G. (2009) · Springer eBooks · doi:10.1007/978-3-540-88489-7_4 · Cited by 1
Self-citationFreyberger, H. J., & Spitzer, C. (2012) · Springer eBooks · doi:10.1007/978-3-642-29897-4_17 · Cited by 1
Ätiopathogenese und Neurobiologie
Priebe, K., Schmahl, C. G., & Stiglmayr, C. (2013) · Springer eBooks · doi:10.1007/978-3-642-35066-5_4 · Cited by 1
Self-citationBATEMAN, A. W., & Zanarini, M. C. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544392.045 · Cited by 2
Un approccio dimensionale al disturbo di personalità borderline
Dell’Osso, B. M., Camuri, G., Berlin, H. A., Serati, M., & Altamura, A. C. (2009) · Cited by 1
Dissoziative Störungen (Konversionsstörungen) (F44)
Weber, S., Mathiak, K., & Schneider, F. (2008) · Springer eBooks · doi:10.1007/978-3-540-78467-8_19
Bohus, M., Stieglitz, R., Fiedler, P. A., Hecht, H., Herpertz, S. C., Müller‐Isberner, R., & Berger, T. (2009) · Elsevier eBooks · doi:10.1016/b978-343722481-2.50025-8
Self-citationSelf-injury and borderline personality disorder
Schmahl, C. G., & Ludäscher, P. (2011) · Neuropsychiatry · doi:10.2217/npy.10.9
Self-citationDissociative disorders: therapeutical approaches
Damşa, C., Pirrotta, R., Lazignac, C., Hyams, H., & Ducrocq, F. (2005)
Dissoziative Störungen (ICD-10 F 44)
Priebe, K., Stiglmayr, C., & Schmahl, C. G. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50018-6
Self-citationThe inpatient with borderline personality disorder
Casher, M. I., & Bess, J. D. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511933783.006 · Cited by 1
Bohus, M., Stieglitz, R., Fiedler, P. A., Hecht, H., Herpertz, S. C., Müller‐Isberner, R., & Berger, T. (2012) · Elsevier eBooks · doi:10.1016/b978-3-437-22483-6.10021-x · Cited by 3
Self-citationLes traitements pharmacologiques des troubles de la personnalité
Bédard-Charette, K. (2000) · Psychiatrie et violence · doi:10.7202/1074966ar
den Boer, J. A., Vahlne, J. O., Post, P., Heck, A. H., Daubenton, F., & Olbrich, R. (2000) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(200004)15:3<179::aid-hup156>3.0.co;2-n · Cited by 38
Schmahl, C. G. (2013) · Springer eBooks · doi:10.1007/978-3-642-35068-9_4
Self-citationSchmahl, C. G. (2019) · Springer eBooks · doi:10.1007/978-3-662-58470-5_6 · Cited by 1
Self-citationKapfhammer, H. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_73-1
Schmahl, C. G. (2022) · Springer eBooks · doi:10.1007/978-3-662-64057-9_6
Self-citationPharmakotherapeutische Ansätze
Priebe, K., Schmahl, C. G., & Stiglmayr, C. (2013) · Springer eBooks · doi:10.1007/978-3-642-35066-5_9
Self-citationDissoziative Störungen (Konversionsstörungen) (F44)
Weber-Papen, S., Mathiak, K., & Schneider, F. W. (2015) · Springer eBooks · doi:10.1007/978-3-642-54571-9_17
Dissoziative Störungen (Konversionsstörungen) (F44)
Weber-Papen, S., Mathiak, K., & Schneider, F. W. (2011) · Springer eBooks · doi:10.1007/978-3-642-17192-5_25
Halder, A., Kundu, P. S., & Ray, S. (2023) · Telangana Journal of Psychiatry · doi:10.4103/tjp.tjp_57_23 · Cited by 1
Dissoziative Störungen und Konversionsstörungen im Kindes- und Jugendalter
Brunner, R. M., & Resch, F. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-49289-5_111-1
Chapter 56. Treatment of Personality Disorders
Hollander, E., Vats, T., & Desilva, N. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as56
Dissoziative Störungen und Konversionsstörungen im Kindes- und Jugendalter
Brunner, R. M., & Resch, F. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-66744-6_111
Chapter 4. Self-Injurious Behaviors
Simeon, D. (2005) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615377329.lg04 · Cited by 1
Grundlagen der Diagnostik und Therapie
(2024) · Elsevier eBooks · doi:10.1016/b978-3-437-22487-4.16001-0
Metadata
- Authors
- Bohus, M. J., Landwehrmeyer, G. B., Stiglmayr, C. E., Limberger, M. F., Böhme, R., & Schmahl, C. G.
- Affiliations
- University of Freiburg (DE)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-09-15
- Volume
- 60
- Issue
- 9
- Pages
- 598-603
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1990256375
- Cited by
- 153
- References
- 0
- Citations by year
- 2025: 1 · 2024: 6 · 2023: 4 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 7 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 6 · 2013: 8 · 2012: 6
- FWCI
- 8.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- naltrexone, borderline personality disorder, dissociative symptoms, flashbacks, post-traumatic stress disorder, opioid system, opioid antagonists, tonic immobility, analgesia, dissociation
- MeSH terms
- Adolescent, Adult, Borderline Personality Disorder, Dissociative Disorders, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Germany, Humans, Middle Aged, Naltrexone, Narcotic Antagonists, Personality Inventory, Psychiatric Status Rating Scales, Severity of Illness Index, Comorbidity, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.